MetLife Remarkets Approx. $1B Debt - Analyst Blog


Earlier this week, MetLife Inc. ( MET ) priced its long-term debentures worth $1.0 billion that are scheduled for remarketing and settlement next week.

Previously, these senior debentures were issued in Nov 2010, and comprised 40 million common equity shares of the company issued in connection with the financing of the acquisition of American Life Insurance Co. (ALICO) and Delaware American Life Insurance Co.

Presently, these debentures are issued at an interest rate of 4.368% and are dated to mature on Sep 15, 2023. The company expects to distribute the proceeds from the debenture sale to the common equity holders against the prior stock purchase contracts.

Meanwhile, MetLife has appointed Morgan Stanley ( MS ), Citigroup Inc. ( C ), Credit Suisse AG ( CS ), HSBC Holdings Plc ( HBC ) and Deutsche Bank AG ( DB ) as the joint book-running managers for the sale.

Ratings Action

Further, the above-mentioned debentures are rated "A3" and "A-" from Moody's Investor Service and Fitch Ratings, respectively. However, Moody's casted a negative outlook on this long-term debt, while Fitch affirmed its stable stance.

Both ratings agencies remain confident of MetLife's capital flexibility, earnings growth potential on the heels of diversified business basket, large scale of operations and brand appreciation. However, Moody's is wary of the pace of growth, which is likely to pose a sluggish trend given the low interest rate environment across developed and emerging economies.

Exposure to variable annuities and spread business further add to the woes. Nonetheless, since last year, MetLife has been strategically shifting toward potential opportunities in the emerging markets and employee benefit products, while driving away from capital-intensive and spread-dependent products.

MetLife's financial leverage stood at 28% at the end of Jun 2013, which the ratings agencies believe should remain within 25%. Moreover, NAIC risk-based capital ratio that was 420% at the end of Jun 2013 should likely be around 450%.

While Fitch expects MetLife's interest coverage of about 8x for 2013, Moody's expect the company to maintain an over 8% return on capital, without depending on variable investment income, for a possible upgrade. Overall, MetLife has the potential to outperform the peer group in future.

While MetLife carries a Zacks Rank #3 (Hold), other outperformers in the insurance sector include EMC Insurance Group Inc. ( EMCI ), Everest Re ( RE ) and Global Indemnity Plc ( GBLI ). All these stocks carry a Zacks Rank #1 (Strong Buy).

CITIGROUP INC (C): Free Stock Analysis Report

CREDIT SUISSE (CS): Free Stock Analysis Report

DEUTSCHE BK AG (DB): Free Stock Analysis Report

EMC INSURANCE (EMCI): Free Stock Analysis Report

GLOBAL INDEMNTY (GBLI): Free Stock Analysis Report

HSBC HOLDINGS (HBC): Free Stock Analysis Report

METLIFE INC (MET): Free Stock Analysis Report

MORGAN STANLEY (MS): Free Stock Analysis Report

EVEREST RE LTD (RE): Free Stock Analysis Report

To read this article on click here.

Zacks Investment Research

The views and opinions expressed herein are the views and opinions of the author and do not necessarily reflect those of The NASDAQ OMX Group, Inc.

This article appears in: Investing , Business , Stocks

Referenced Stocks: C , CS , DB , EMCI , GBLI

More from

Related Videos

Quick on Your Feet
Quick on Your Feet                  
Early Entrepreneurship
Early Entrepreneurship              
Trying to Be Goofy
Trying to Be Goofy                  



Most Active by Volume

  • $16.09 ▲ 0.50%
  • $102.50 ▲ 0.24%
  • $19.57 ▲ 2.35%
  • $49.75 ▲ 0.65%
  • $34.92 ▲ 0.78%
  • $3.63 ▲ 0.83%
  • $13.06 ▼ 0.38%
  • $74.82 ▲ 1.31%
As of 8/29/2014, 04:04 PM

Find a Credit Card

Select a credit card product by:
Select an offer:
Data Provided by